Richard A. Flavell, PhD, D.Sc, FRS, HHMI Investigator, Sterling Professor of Immunobiology, Yale School of Medicine and Michael Crackower, PhD, Chief Scientific Officer, Ventus Therapeutics
News
Making progress and achieving milestones to create innovative medicines
